SPRO Summary

  1. NASDAQ
  2. >
  3. SPRO
TickerSPRO
DescriptionSPERO THERAPEUTICS INC
Spero Therapeutics, Inc. is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multi-drug-resistant (MDR) bacterial infections and rare diseases.
ExchangeNASDAQ
TypeStock
SectorHealthcare
Employees89
Next Earnings DateNovember 4th, 2021
IV91.552167%
IV Percentile55th
IV Rank32.50%
IV Skew4.826209
IV Skew Percentile41st
IV Skew SentimentNeutral
Option Volume136
Volume6,447
Price$17.11
Previous Close$17.14
52-Week High$23.639
52-Week Low$11.75
50-Day Moving Avg.$18.18
200-Day Moving Avg.$15.25
10-Day Avg. Volume53,288
20-Day Avg. Volume92,042
30-Day Avg. Volume90,316
3-Month Avg. Volume118,197
EPS-$2.75
Outstanding Shares32,146,847
Market Capitalization$543,603,200
CurrencyUSD
UpdatedOctober 20th, 2021